Skip to main content

Advertisement

Log in

Genetic polymorphism of XRCC3 Thr241Met and breast cancer risk: case-control study in Korean women and meta-analysis of 12 studies

  • Epidemiology
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

To evaluate the relationship of genetic polymorphism in XRCC3 Thr241Met and the risk of breast cancer, a hospital-based case-control study was conducted in Korea. Histologically confirmed breast cancer cases (n = 574) and controls (n = 502) with no present or previous history of cancer were recruited from several teaching hospitals in Seoul during 1995–2001. Information on demographic characteristics and other information were collected by interviewed questionnaire. Genetic polymorphisms of XRCC3 Thr241Met (C > T) was determined by single base extention assay. The frequency of Thr/Thr, Thr/Met, and Met/Met genotype were 89.4, 10.4, 0.2% in cases and 92.3, 7.7, 0.0% in controls, respectively. Genotype distribution in controls fit well to the Hardy–Weinberg equilibrium (P = 0.74). XRCC3 codon 241 Thr/Met or Met/Met genotype moderately increased the risk of breast cancer (OR = 1.4, 95% CI: 0.87–2.33), but not significant in this study. In the results of meta-analysis using twelve reports, however, Thr/Met or Met/Met genotype increased the risk of breast cancer (OR = 1.08, 95%CI: 1.00–1.17). In conclusion, although the genetic polymorphism of XRCC3 Thr241Met was unlikely to have a substantial overall association in Korean women, the meta-analysis of studies, including ours, provided that Thr/Met and Met/Met was weakly increased the risk of breast cancer compare to Thr/Thr genotype.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Wakeford R (2004) The cancer epidemiology of radiation. Oncogene 23:6404–6428

    Article  PubMed  CAS  Google Scholar 

  2. Ronckers CM, Erdman CA, Land CE, (2005) Radiation and breast cancer: a review of current evidence. Breast Cancer Res 7:21–32

    Article  PubMed  Google Scholar 

  3. John EM, Kelsey JL (1993) Radiation and other environmental exposures and breast cancer. Epidemiol Rev 15:157–162

    PubMed  CAS  Google Scholar 

  4. Holmberg E, Holm LE, Lundell M, Mattsson A, Wallgren A, Karlsson P (2001) Excess breast cancer risk and the role of parity, age at first childbirth and exposure to radiation in infancy. Br J Cancer 85:362–366

    Article  PubMed  CAS  Google Scholar 

  5. Parshad R, Price FM, Bohr VA, Cowans KH, Zujewski JA, Sanford K (1996) Deficient DNA repair capacity, a predisposing factor in breast cancer. Br J Cancer 74:1–5

    PubMed  CAS  Google Scholar 

  6. Kuschel B, Auranen A, McBride S, Novik KL, Antoniou A, Lipscombe JM, Day NE, Easton DF, Ponder BA, Pharoah PD, Dunning A (2002) Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Genet 11(12):1399–1407

    Article  PubMed  CAS  Google Scholar 

  7. Smith TR, Miller MS, Lohman K, Lange EM, Case LD, Mohrenweiser HW, Hu JJ (2003) Polymorphisms of XRCC1 and XRCC3 genes and susceptibility to breast cancer. Cancer Lett 190:183–190

    Article  PubMed  CAS  Google Scholar 

  8. Han J, Hankinson SE, Ranu H, De Vivo I, Hunter DJ (2004) Polymorphisms in DNA double-strand break repair genes and breast cancer risk in the Nurses’ Health Study. Carcinogenesis 25(2):189–195

    Article  PubMed  CAS  Google Scholar 

  9. Smith TR, Levine EA, Perrier ND, Miller MS, Freimanis RI, Lohman K, Case LD, Xu J, Mohrenweiser HW, Hu JJ (2003) DAN-repair genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 12:1200–1204

    PubMed  CAS  Google Scholar 

  10. Jacobsen NR, Nexo BA, Olsen A, Overvad K, Wallin H, Tjonneland A, Vogel U (2003) No association between the DNA repair gene XRCC3 T241M polymorphism and risk of skin cancer and breast cancer. Cancer Epidemiol Biomarkers Prev 12:584–585

    Google Scholar 

  11. Millikan RC, Player JS, Decotret AR, Tse CK, Keku T (2005) Polymorphisms in DNA Repair genes, medical exposure to ionizing radiation, and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14(10):2326–2334

    Article  PubMed  CAS  Google Scholar 

  12. Figueiredo JC, Knight JA, Briollais L, Andrulis IL, Ozcelik H (2004) Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk at the Ontario site of the breast cancer family registry. Cancer Epidemiol Biomarkers Prev 13(4): 583–591

    PubMed  CAS  Google Scholar 

  13. Webb PM, Hopper JL, Newman B, Chen X, Kelemen L, Giles GG, Southey MC, Chenevix-Trench G, Spurdle AB (2005) Double-strand break repair gene polymorphisms and risk of breast or ovarian cancer. Cancer Epidemiol Biomarkers Prev 14(2):319–323

    Article  PubMed  CAS  Google Scholar 

  14. Zhang L, Zhang Z, Yan W (2005) Single nucleotide polymorphisms for DNA repair genes in breast cancer patients. Clin Chim Acta 359:150–155

    Article  PubMed  CAS  Google Scholar 

  15. Forsti A, Angelini S, Festa F, Sanyal S, Zhang Z, Grzybowska E, Pamula J, Pekala W, Zientek H, Hemminki K, Kumar R (2004) Single nucleotide polymorphisms in breast cancer. Oncol Rep 11:917–922

    PubMed  Google Scholar 

  16. Garcia-Closas M, Egan KM, Newcomb PA, Brinton LA, Titus-Ernstoff L, Chanock S, Welch R, Lissowska J, Peplonska B, Szeszenia-Dabrowska N, Zatonski W, Bardin-Mikolajczak, Struewing JP (2006) Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. Hum Genet 119(4):376–388

    Article  PubMed  CAS  Google Scholar 

  17. Lee SA, Lee KM, Park WY, Kim B, Nam J, Yoo KY, Noh DY, Ahn SH, Hirvonen A, Kang D (2005) Obesity and genetic polymorphism of ERCC2 and ERCC4 as modifier of risk of breast cancer. Exp Mol Med 37(2):86–90

    PubMed  CAS  Google Scholar 

  18. Park SK, Yoo KY, Lee SJ, Kim SU, Ahn SH, Noh DY, Choe KJ, Strickland PT, Hirvonen A, Kang D (2000) Alcohol consumption, glutathione S-transferase M1 and T1 genetic polymorphisms and breast cancer risk. Pharmacogenetics 10:301–309

    Article  CAS  Google Scholar 

  19. Dersimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188

    Article  PubMed  CAS  Google Scholar 

  20. Cohran WG (1983) Adjustments in analysis. In: Moses LE, Mosteller F (eds.), Planning and analysis of observational studies. Wiley, New York, pp 102–108

    Article  Google Scholar 

  21. Whitehead A, Whitehead J (1991) A general parametric approach to the meta-analysis of randomized clinical trials. Stat Med 10:1665–1677

    PubMed  CAS  Google Scholar 

  22. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–101

    Article  PubMed  CAS  Google Scholar 

  23. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634

    PubMed  CAS  Google Scholar 

  24. Matullo G, Palli D, Peluso M, Guarrera S, Carturan S, Celentano E, Krogh V, Munnia A, Tumino R, Polidoro S, Piazza A, Vineis P (2001) XRCC1, XRCC3, XPD gene polymorphisms, smoking and 32P-DNA adducts in a sample of healthy subjects. Carcinogenesis 9:1437–1445

    Article  Google Scholar 

  25. Au WW, Salama SA, Sierra-Torres CH (2003) Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ Health Perspect 111:1843–1850

    PubMed  CAS  Google Scholar 

  26. Savas S, Kim DY, Ahmad MF, Shariff M, Ozcelik H (2004) Identifying functional genetic variants in DNA repair pathway using protein conservation analysis. Cancer Epidemiol biomarkers Prev 13:801–807

    PubMed  CAS  Google Scholar 

  27. Han J, Hankinson SE, Zhang SM, DeVivo I, Hunter DJ (2004) Interaction between genetic variations in DNA repair genes and plasma folate on breast cancer risk. Cancer Epidemiol Biomarkers Prev 13:520–524

    Article  PubMed  CAS  Google Scholar 

  28. Manuguerra M, Saletta F, Karagas MR, Berwick M, Veglia F, Vineis P, Matullo G XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review. Am J Epidemol (Epub ahead of print)

  29. Shen H, Wang X, Hu Z, Zhang Z, Xu Y, Hu X, Guo J, Wei Q (2004) Polymorphisms of DNA repair gene XRCC3 Thr241Met and risk of gastric cancer in a Chinese population. Cancer Lett 206:51–58

    Article  PubMed  CAS  Google Scholar 

  30. Jin M, Chen K, Song L, Fan CH, Chen Q, Zhu YM, Ma XY, Yao KY (2005) The association of the DNA repair gene XRCC3 Thr241met polymorphism with susceptibility to colorectal cancer in a Chinese population. Cancer Genet Cytogenet 163:38–43

    Article  PubMed  CAS  Google Scholar 

  31. Yeh CC, Sung FC, Tang R, Chang-Chieh CR, Hsieh LL (2005) Polymorphisms of the XRCC1, XRCC3, and XPD genes, and colorectal cancer risk: a case-control study in Taiwan. BMC Cancer 5:12–19

    Article  PubMed  Google Scholar 

  32. Ritchey JD, Huang WY, Chokkalingam AP, Gao YT, Deng J, Levine P, Stanczyk FZ, Hsing AW (2005) Genetic variants of DNA repair genes and prostate cancer: a population-based study. Cancer Epidemiol biomarkers Prev 14(7):1703–1709

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (0620410–1).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daehee Kang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, SA., Lee, KM., Park, S.K. et al. Genetic polymorphism of XRCC3 Thr241Met and breast cancer risk: case-control study in Korean women and meta-analysis of 12 studies. Breast Cancer Res Treat 103, 71–76 (2007). https://doi.org/10.1007/s10549-006-9348-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-006-9348-z

Keywords

Navigation